Copyright indiatimes
RelatedWhat’s powering Mounjaro’s rise to the top of Indian drug marketIndia strategic launchpad for next wave of obesity care Eli Lilly's blockbuster obesity drug Mounjaro became India's top-selling drug by value for the month of October with sales hitting 1 billion rupees ($11.38 million), research firm Pharmarack said on Friday. Demand for the blockbuster anti-obesity drugs, which help control blood sugar and slow digestion, has been on an upswing in the world's most populous nation.Lilly launched Mounjaro in March, beating rival Novo Nordisk's Wegovy launch in June, and has since generated a revenue of 3.33 billion rupees till end of October, the firm said.Mounjaro's consumption in India by volume was 10 times more than Wegovy in October, the firm said. Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our Economic Times WhatsApp channel) Read More News onMounjaroobesity drugEli LillyNovo Nordiskobesity treatmentWegovymounjaro s consumptionweight loss medicines (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online....moreless (You can now subscribe to our Economic Times WhatsApp channel)Read More News onMounjaroobesity drugEli LillyNovo Nordiskobesity treatmentWegovymounjaro s consumptionweight loss medicines(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online....moreless
